Evidence map›Paper›PMID 41072972›Full record

ArticleJACC. Case reports2025

Imaging Pitfalls in the Detection of Infiltrative Cardiomyopathies.

Patricia M Carey, Grace Hagan, John P Bois

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Patricia M CareyDepartment of Internal Medicine, Mayo Clinic College of Medicine & Science, Rochester, Minnesota, USA. Electronic address: carey.patricia@mayo.edu.
Grace HaganDepartment of Internal Medicine, Mayo Clinic College of Medicine & Science, Rochester, Minnesota, USA.
John P BoisDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite increasing recognition of infiltrative cardiomyopathies, the heterogeneous group of diseases remains difficult to diagnose. CASE SUMMARY: We present an 82-year-old man with septal basal thickening initially thought to be hypertrophic cardiomyopathy. Further imaging was suspicious for sarcoidosis, but after several years without clinical improvement and the interval development of concentric hypertrophy, he was diagnosed with cardiac amyloidosis. DISCUSSION: Advanced imaging modalities are frequently used to evaluate suspected infiltrative cardiomyopathies. However, the effectiveness of imaging can be limited by the variable presentations of both sarcoid and amyloid. In this case, cardiac amyloidosis initially appeared on imaging with features characteristic of cardiac sarcoidosis on both positron emission tomography and cardiac magnetic resonance. Despite advancements in imaging technology, diagnostic limitations persist, potentially leading to misdiagnosis and delayed treatment. TAKE-HOME MESSAGES: Despite increasing recognition, cardiac amyloid and cardiac sarcoid are difficult to diagnose and require a high degree of clinical suspicion. Multimodality imaging can help discriminate between cardiomyopathies. However, limitations with current imaging modalities may lead to further diagnostic uncertainty.

Indexed as

awarenesscardiac magnetic resonancecardiomyopathyechocardiographyimagingnuclear medicineposition emission tomography

Identifiers

PMID41072972
PMCPMC12516268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.